Completed NA INTERVENTIONAL 6-arm NCT03463837

Identify Biomarkers of Tobacco Exposure and Nicotine Uptake From JUUL 5% in Adult Smokers (Diamond)

A Randomized, Open-Label, Parallel-Group Study to Characterize Biomarkers of Tobacco Exposure and Nicotine Uptake From JUUL 5% Electronic Nicotine Delivery Systems (ENDS) in Adult Smokers

Sponsor: Celerion

Conditions Nicotine Dependence, Other Tobacco Product Smoking, Tobacco Tobacco Use

Interventions Combustible cigarette JUUL 5%, Creme Bruele, ENDS Smoking Cessation Treatment with JUUL 5%, Cool Mint, ENDS Treatment with JUUL 5%, Mango, ENDS Treatment with JUUL 5%, Virginia Tobacco

Updated 12 times since 2018 Last updated: Jun 15, 2021 Started: Mar 4, 2018 Primary completion: Jul 27, 2018 Completion: Aug 13, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Nicotine Dependence, Other Tobacco Product and Smoking, Tobacco, this trial is completed. The trial is conducted by Celerion and has accumulated 12 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

12 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Sep 2021 [monthly]

Completed NA
Feb 2020 — Jan 2021 [monthly]

Completed NA

▶ Show 7 earlier versions

Feb 2019 — Feb 2020 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Nov 2018 — Feb 2019 [monthly]

Active Not Recruiting NA
Sep 2018 — Nov 2018 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Jul 2018 — Sep 2018 [monthly]

Recruiting NA
Jun 2018 — Jul 2018 [monthly]

Recruiting NA
May 2018 — Jun 2018 [monthly]

Recruiting NA
Mar 2018 — May 2018 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Celerion
Juul Labs, Inc.

Data source: Juul Labs, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lincoln, United States